Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes


Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides


Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Customer Service

Special Offers

View our current special offers

ECACC Cell Lines

Available in days - not weeks

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

Offer Of The Month

Ionic Liquid Capillary GC Columns - Save 30%

News & Information

St. Louis, MO - February 24, 2015 Cerilliant Introduces Certified Spiking Solutions® of Tryptamines

Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business is introducing  eight new Certified Spiking Solutions® of tryptamines for use in quantitative mass spec-based testing applications such as forensic analysis, clinical toxicology, urine drug testing, or pharmaceutical research. This product introduction includes solution CRMs for five synthetic tryptamines 5-MeO-AMT, 5-MeO-DALT, 5-MeO-MiPT, 5-MeO-DMT, and 5-MeO-DiPT in addition to three naturally occurring tryptamines N, N-dimethyltryptamine; psilocybin; and its stable-labeled internal standard.

Read More
St. Louis, MO - February 18, 2015 Sigma® Life Science Releases Next-Gen Sequencing Oligos

Custom Next-Generation Sequencing Adapters Improve Target Sequence Assembly

Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly. These oligos are expected to allow researchers to achieve better results from multiplexing experiments.

Read More
St. Louis, MO - January 29, 2015 Sigma-Aldrich and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration

Sigma-Aldrich Corporation's (NASDAQ: SIAL) Research business unit, which supports scientific research by supplying products, services and solutions, today announced it has entered into a new gene editing collaboration with the Institute of Molecular Genetics (IMG) at the Czech Center for Phenogenomics (CCP) in Prague. Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at IMG/CCP with Sigma CRISPR technology, including reagents, experimental design consultation and dedicated gene editing bioinformaticians.

Read More
St. Louis, MO - January 22, 2015 Sigma-Aldrich and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research Tools

Alliance will leverage Sigma-Aldrich's leading manufacturing and global distribution capabilities to provide accelerated access to VIB's innovative research products, tools and technologies

Sigma-Aldrich Corporation's (NASDAQ: SIAL) Research business unit, an industry leader in supporting translational researchers by supplying the products, services and solutions needed to enable scientific discovery, has formed an alliance with VIB, a leading life science research institute based in Flanders, Belgium, focused on translational research in medical, agricultural and industrial applications. The alliance will focus on the commercialization and supply of new tools and technologies to help meet the evolving needs of translational researchers.

Read More